Stay updated on OpACIN-neo Optimal Combo Trial
Sign up to get notified when there's something new on the OpACIN-neo Optimal Combo Trial page.

Latest updates to the OpACIN-neo Optimal Combo Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.5.4 is now shown on the page, replacing the previous Revision: v3.5.3, indicating a small maintenance update to the page.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRevision label updated to v3.5.3, replacing the previous v3.5.2. This indicates a new page revision without altering the trial information.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision label updated to v3.5.2, replacing the previous v3.5.0.SummaryDifference0.0%

- Check61 days agoChange Detected- Added the Nat Med 2026 PRADO-trial publication: Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis (Nat Med, 2026 Mar;32(3):952-963; Epub 2026 Jan 28). - Removed the earlier Nat Med ahead-of-print citation (Nat Med, 2026 Jan 28).SummaryDifference0.0%

- Check75 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No user-facing content changes were observed on the page.SummaryDifference0.0%

- Check82 days agoChange DetectedPage revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to OpACIN-neo Optimal Combo Trial
Enter your email address, and we'll notify you when there's something new on the OpACIN-neo Optimal Combo Trial page.